Innovent Biologics, Inc. carries a market capitalization of 18.09B, placing it among publicly traded companies globally.
| Market Cap | 18.09B |
| Enterprise Value | N/A |
Innovent Biologics, Inc.'s stock has gained approximately 26.40485% over the past 52 weeks. The 50-day moving average sits at 10.77, while the 200-day moving average is 11.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | 26.40485% |
| 50-Day Moving Average | 10.77 |
| 200-Day Moving Average | 11.17 |
| Average Volume (20 Days) | N/A |